Media Summary: CRS occurs when the innate and adaptive immune systems are overactivated, ONS member Theresa Latchford, RN, MS, AOCNS®, BMTCN®, clinical nurse specialist at Stanford Health Care in Palo Alto, CA, ... Bianca Santomasso, MD, PhD, of the Memorial Sloan Kettering Cancer Center, New York City, NY, discusses the manifestations ...

Cytokine Release - Detailed Analysis & Overview

CRS occurs when the innate and adaptive immune systems are overactivated, ONS member Theresa Latchford, RN, MS, AOCNS®, BMTCN®, clinical nurse specialist at Stanford Health Care in Palo Alto, CA, ... Bianca Santomasso, MD, PhD, of the Memorial Sloan Kettering Cancer Center, New York City, NY, discusses the manifestations ... CAR T-cell therapy is a new and exciting advancement for the treatment of hematological cancers. In this interview, Rose Ellard ... Anna Minchom, MD, BCh, MB, MRCP, The Royal Marsden Hospital, London, UK, discusses the management of Dr Graham talks with ecancer at the ACP immunotherapy workshop about CRS, a side effect associated with recently approved ...

This training program offers a comprehensive clinical overview of immune-related adverse events, specifically focusing on ... The inflammation induced by medication can create challenges when producing novel treatments. In this interview, Prof. A 56 year old female presented to the emergency department with confusion after initiating a new cancer drug. She was ... Brian W. Soper, Ph.D. speaks about the efficacy and safety of therapeutics in immuno-modulatory induced Earn CME for related activities: In this presentation from the 'Keeping Up With CAR T-cell Therapies ... Partow Kebriaei, MD, of MD Anderson Cancer Center, discusses what to be aware of when treating patients who have undergone ...

Daniel W. Lee, MD, University of Virginia, Charlottesville, VA, talks on the management of Yan Chen, MD, PhD, Elpis Biopharmaceuticals, Boston, MA, outlines methods for managing the adverse events (AEs) associated ... Leading oncologists come together to discuss emerging treatment options and data regarding blood cancer, including multiple ... Product Characterization Scientist, Rachel Wood, introduces the multiplexed We've talked about how immune cells communicate with one another using

Photo Gallery

What is Cytokine Release Syndrome or CRS?
CRS Explained: Understanding Cytokine Release Syndrome in CAR-T Therapy
Episode 176: Oncologic Emergencies 101: Cytokine Release Syndrome
Management of cytokine release syndrome and neurotoxicity: an emerging need
Cytokine release syndrome in CAR T-cell therapy
Managing cytokine release syndrome in T-cell engager therapies for small cell lung cancer
Managing cytokine release syndrome
CAR T–Associated Cytokine Release Syndrome
Cytokine Release Syndrome (CRS) and Immune Effector Cell-associated Neurotoxicity Syndrome (ICANS)
Cytokine release syndrome: a limiting factor for AML treatment
Cytokine Release Syndrome
Cytokine Release Syndrome in Children - Virtual CME - DAY 3
View Detailed Profile
What is Cytokine Release Syndrome or CRS?

What is Cytokine Release Syndrome or CRS?

CRS occurs when the innate and adaptive immune systems are overactivated,

CRS Explained: Understanding Cytokine Release Syndrome in CAR-T Therapy

CRS Explained: Understanding Cytokine Release Syndrome in CAR-T Therapy

Cytokine Release

Episode 176: Oncologic Emergencies 101: Cytokine Release Syndrome

Episode 176: Oncologic Emergencies 101: Cytokine Release Syndrome

ONS member Theresa Latchford, RN, MS, AOCNS®, BMTCN®, clinical nurse specialist at Stanford Health Care in Palo Alto, CA, ...

Management of cytokine release syndrome and neurotoxicity: an emerging need

Management of cytokine release syndrome and neurotoxicity: an emerging need

Bianca Santomasso, MD, PhD, of the Memorial Sloan Kettering Cancer Center, New York City, NY, discusses the manifestations ...

Cytokine release syndrome in CAR T-cell therapy

Cytokine release syndrome in CAR T-cell therapy

CAR T-cell therapy is a new and exciting advancement for the treatment of hematological cancers. In this interview, Rose Ellard ...

Managing cytokine release syndrome in T-cell engager therapies for small cell lung cancer

Managing cytokine release syndrome in T-cell engager therapies for small cell lung cancer

Anna Minchom, MD, BCh, MB, MRCP, The Royal Marsden Hospital, London, UK, discusses the management of

Managing cytokine release syndrome

Managing cytokine release syndrome

Dr Graham talks with ecancer at the ACP immunotherapy workshop about CRS, a side effect associated with recently approved ...

CAR T–Associated Cytokine Release Syndrome

CAR T–Associated Cytokine Release Syndrome

Cytokine release

Cytokine Release Syndrome (CRS) and Immune Effector Cell-associated Neurotoxicity Syndrome (ICANS)

Cytokine Release Syndrome (CRS) and Immune Effector Cell-associated Neurotoxicity Syndrome (ICANS)

This training program offers a comprehensive clinical overview of immune-related adverse events, specifically focusing on ...

Cytokine release syndrome: a limiting factor for AML treatment

Cytokine release syndrome: a limiting factor for AML treatment

The inflammation induced by medication can create challenges when producing novel treatments. In this interview, Prof.

Cytokine Release Syndrome

Cytokine Release Syndrome

A 56 year old female presented to the emergency department with confusion after initiating a new cancer drug. She was ...

Cytokine Release Syndrome in Children - Virtual CME - DAY 3

Cytokine Release Syndrome in Children - Virtual CME - DAY 3

Cytokine release

Efficacy and Safety of Therapeutics in Immuno-modulatory Induced Cytokine Release Syndrome

Efficacy and Safety of Therapeutics in Immuno-modulatory Induced Cytokine Release Syndrome

Brian W. Soper, Ph.D. speaks about the efficacy and safety of therapeutics in immuno-modulatory induced

CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity

CAR-T: Management of Cytokine Release Syndrome and Neurotoxicity

Earn CME for related activities: https://www.naccme.com/oln In this presentation from the 'Keeping Up With CAR T-cell Therapies ...

Partow Kebriaei on Monitoring Patients for Cytokine Release Syndrome

Partow Kebriaei on Monitoring Patients for Cytokine Release Syndrome

Partow Kebriaei, MD, of MD Anderson Cancer Center, discusses what to be aware of when treating patients who have undergone ...

The management of cytokine release syndrome

The management of cytokine release syndrome

Daniel W. Lee, MD, University of Virginia, Charlottesville, VA, talks on the management of

Managing cytokine release syndrome during CAR-T cell therapy

Managing cytokine release syndrome during CAR-T cell therapy

Yan Chen, MD, PhD, Elpis Biopharmaceuticals, Boston, MA, outlines methods for managing the adverse events (AEs) associated ...

Q&A: How Can I Reduce my Risk of Cytokine Release Syndrome (CRS)? - Blood Cancer OncTalk 2023

Q&A: How Can I Reduce my Risk of Cytokine Release Syndrome (CRS)? - Blood Cancer OncTalk 2023

Leading oncologists come together to discuss emerging treatment options and data regarding blood cancer, including multiple ...

Understanding Cytokine Activation

Understanding Cytokine Activation

Product Characterization Scientist, Rachel Wood, introduces the multiplexed

Cytokines and Chemokines

Cytokines and Chemokines

We've talked about how immune cells communicate with one another using